Close Menu

NEW YORK – Cancer sequencing firm Personalis reported after the close of the market on Tuesday that its second quarter 2019 revenues were up 80 percent year over year.

In its first quarterly earnings report after closing a $140 million initial public offering in June, the company recorded total revenues of $15.8 million compared to $8.8 million in Q2 2018, beating analysts' consensus estimate of $14.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.